Annual Operating Expenses
$113.83 M
-$93.98 M-45.22%
December 31, 2024
Summary
- As of March 10, 2025, MRSN annual total operating expenses is $113.83 million, with the most recent change of -$93.98 million (-45.22%) on December 31, 2024.
- During the last 3 years, MRSN annual operating expenses has fallen by -$55.07 million (-32.60%).
- MRSN annual operating expenses is now -50.58% below its all-time high of $230.35 million, reached on December 31, 2022.
Performance
MRSN Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$31.17 M
+$6.50 M+26.37%
December 31, 2024
Summary
- As of March 10, 2025, MRSN quarterly total operating expenses is $31.17 million, with the most recent change of +$6.50 million (+26.37%) on December 31, 2024.
- Over the past year, MRSN quarterly operating expenses has stayed the same.
- MRSN quarterly operating expenses is now -53.58% below its all-time high of $67.16 million, reached on June 30, 2023.
Performance
MRSN Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MRSN Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.2% | 0.0% |
| 3 y3 years | -32.6% | 0.0% |
| 5 y5 years | +57.4% | 0.0% |
MRSN Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -50.6% | at low | -53.6% | +26.4% |
| 5 y | 5-year | -50.6% | +57.4% | -53.6% | +87.3% |
| alltime | all time | -50.6% | +326.3% | -53.6% | +244.2% |
Mersana Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $113.83 M(-45.2%) | $31.17 M(+26.4%) |
| Sep 2024 | - | $24.67 M(-11.1%) |
| Jun 2024 | - | $27.75 M(-8.3%) |
| Mar 2024 | - | $30.25 M(-4.4%) |
| Dec 2023 | $207.81 M(-9.8%) | $31.63 M(-27.2%) |
| Sep 2023 | - | $43.42 M(-35.3%) |
| Jun 2023 | - | $67.16 M(+2.4%) |
| Mar 2023 | - | $65.60 M(+8.4%) |
| Dec 2022 | $230.35 M(+36.4%) | $60.51 M(-7.2%) |
| Sep 2022 | - | $65.21 M(+16.4%) |
| Jun 2022 | - | $56.03 M(+15.3%) |
| Mar 2022 | - | $48.59 M(+1.1%) |
| Dec 2021 | $168.90 M(+89.9%) | $48.04 M(+5.8%) |
| Sep 2021 | - | $45.40 M(+11.2%) |
| Jun 2021 | - | $40.84 M(+18.0%) |
| Mar 2021 | - | $34.62 M(+20.3%) |
| Dec 2020 | $88.94 M | $28.77 M(+28.3%) |
| Sep 2020 | - | $22.43 M(+9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $20.58 M(+20.0%) |
| Mar 2020 | - | $17.16 M(+3.1%) |
| Dec 2019 | $72.32 M(-5.1%) | $16.64 M(-8.2%) |
| Sep 2019 | - | $18.14 M(+1.0%) |
| Jun 2019 | - | $17.96 M(-8.3%) |
| Mar 2019 | - | $19.59 M(-18.3%) |
| Dec 2018 | $76.25 M(+33.4%) | $23.97 M(+22.5%) |
| Sep 2018 | - | $19.56 M(+15.8%) |
| Jun 2018 | - | $16.89 M(+6.7%) |
| Mar 2018 | - | $15.83 M(-10.1%) |
| Dec 2017 | $57.16 M(+46.6%) | $17.61 M(+23.0%) |
| Sep 2017 | - | $14.32 M(+11.6%) |
| Jun 2017 | - | $12.83 M(+3.5%) |
| Mar 2017 | - | $12.40 M(+15.0%) |
| Dec 2016 | $38.99 M(+46.0%) | $10.79 M(+17.8%) |
| Sep 2016 | - | $9.15 M(-8.4%) |
| Jun 2016 | - | $10.00 M(+10.4%) |
| Mar 2016 | - | $9.06 M |
| Dec 2015 | $26.70 M | - |
FAQ
- What is Mersana Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Mersana Therapeutics?
- What is Mersana Therapeutics annual operating expenses year-on-year change?
- What is Mersana Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly operating expenses year-on-year change?
What is Mersana Therapeutics annual total operating expenses?
The current annual operating expenses of MRSN is $113.83 M
What is the all time high annual operating expenses for Mersana Therapeutics?
Mersana Therapeutics all-time high annual total operating expenses is $230.35 M
What is Mersana Therapeutics annual operating expenses year-on-year change?
Over the past year, MRSN annual total operating expenses has changed by -$93.98 M (-45.22%)
What is Mersana Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of MRSN is $31.17 M
What is the all time high quarterly operating expenses for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly total operating expenses is $67.16 M
What is Mersana Therapeutics quarterly operating expenses year-on-year change?
Over the past year, MRSN quarterly total operating expenses has changed by $0.00 (0.00%)